Transaction Details

Footnotes

The price is the closing market price of Organon & Co. ("Organon") common stock on Monday, March 30, 2026, as required by the plan under which the Restricted Stock Units ("RSU") were awarded. | On March 31, 2026, the Reporting Person was granted 183,639 RSUs, with each RSU representing a contingent right to receive one share of Organon common stock. These RSUs will vest and become exercisable in three equal installments on March 31, 2027, March 31, 2028, and March 31, 2029. | Each RSU represents a contingent right to receive one share of Organon common stock. | On March 31, 2023, the Reporting Person was granted 19,664 RSUs. Two-thirds of such RSUs previously vested, and the remaining one-third vested on March 31, 2026. | On March 31, 2025, the Reporting Person was granted 36,937 RSUs. One-third of such RSUs vested on March 31, 2026, with the remaining two-thirds to vest on March 31, 2027 and March 31, 2028.